Minit Shah

10PUBLICATIONS
66CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 01, 2026
SMARCA4-deficient Anaplastic Thyroid Carcinoma: A Hitherto Unreported Case.

|Aug 20, 2026
KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Apr 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial.

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Dec 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

Atul Tiwari, Ajay Kumar Singh, Vanita Noronha

Pageof 2

Frequent Collaborators

8 joint publications

Vinita Noronha

8 joint publications

Nandini Menon

7 joint publications

Kumar Prabhash

4 joint publications

Vijay Patil